|
AU2002252192A1
|
|
Methods and primers for evaluating hiv-1 mutations
|
|
GB0402068D0
|
|
Method and kit for evaluation of HIV mutations
|
|
GB0402064D0
|
|
Method and kit for evaluation of HIV mutations
|
|
US6582577B1
|
|
Electrophoresis gel cassette
|
|
US6397150B1
|
|
Method and apparatus for sequencing of DNA using an internal calibrant
|
|
US6436641B1
|
|
Method and apparatus for DNA sequencing
|
|
US6136172A
|
|
Gel-forming insert for electrophoresis gels
|
|
EP1137803A1
|
|
Method and kit for the characterization of antibiotic-resistance mutations in mycobacterium tuberculosis
|
|
US6265152B1
|
|
Method and kit for evaluation of HIV mutations
|
|
AU4355899A
|
|
Method for sequencing nucleic acids with reduced errors
|
|
AU4673399A
|
|
Use of polymorphisms as a predictor of drug-resistance mutations
|
|
US6214555B1
|
|
Method compositions and kit for detection
|
|
CA2266755A1
|
|
Method for sequencing of nucleic acid polymers
|
|
WO9933477A1
|
|
Drug-directed mutagenesis/drug-driven selection for lethal mutants
|
|
AU9249398A
|
|
Method and kit for evaluation of HIV mutations
|
|
AU8846898A
|
|
Method and kit for hla class i typing dna
|
|
AU7878298A
|
|
Apparatus for preparing gels for use in electrophoretic separations and similar applications
|
|
US6024854A
|
|
Method and apparatus for improving electrophoresis resolution
|
|
US6045993A
|
|
Method, reagent and kit for genotyping of human papillomavirus
|
|
US6413718B1
|
|
Method for sequencing of nucleic acid polymers
|
